In a nutshell This study aimed to investigate the surgical treatment of benign prostatic hyperplasia (BPH) using Holmium laser enucleation of the prostate (HOLEP) after failed UroLift. This study showed that HOLEP can be safely used after UroLift. Some background Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the...
Read More
In a nutshell This study aimed to compare quality-of-life between photoselective-vaporization (PVP) and holmium-laser-enucleation of the prostate (HLE) in benign-prostatic-hyperplasia (BPH). This study found that both treatments improved the quality of life for patients with BPH. Some background Benign prostatic...
Read MoreIn a nutshell This study made treatment recommendations in the treatment of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). Some background Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. BPH can impede the flow of urine. This leads to lower urinary...
Read More
In a nutshell This study aimed to investigate Rezum, a new method of treating an enlarged prostate. This study found that Rezum was safe and effective in the treatment of urinary symptoms in these patients. Some background Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. BPH can impede...
Read More
In a nutshell This study aimed to evaluate the link between smoking, metabolic syndrome (MetS) and side-effects after prostate surgery. This study found smoking and MetS led to a higher risk of nocturia (waking at night to urinate). Some background Transurethral resection of the prostate (TURP) is a surgery used to treat urinary problems due...
Read More
In a nutshell This study aimed to investigate the use of cholecalciferol (vitamin D3) for the prevention of recurrent urinary tract infections (UTIs) for men with benign prostate hyperplasia (BPH). This study found that vitamin D3 supplementation may be protective against recurrent UTIs among patients with BPH. Some background People diagnosed with...
Read More
In a nutshell This article investigated the safety and effectiveness of botulinum toxin-A (BTX-A) injections for the treatment of the lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). The authors concluded that BTX-A injections are a safe and effective treatment option for these patients. Some background Lower...
Read More
In a nutshell This article investigated the safety and effectiveness of multipulse laser vaporesection of the prostate (MPVP) vs plasmakinetic resection of the prostate (PKRP) for patients with benign prostate obstruction (BPO). The authors concluded that MPVP might be a better treatment option for patients with BPO. Some background...
Read More
In a nutshell This article investigated the long-term safety and effectiveness of Aquablation vs transurethral resection of the prostate (TURP) for the treatment of urinary symptoms related to benign prostate hyperplasia (BPH; an enlarged prostate). The authors concluded that the two procedures had similar safety and effectiveness after 2 years. Some...
Read More
In a nutshell The authors analyzed the effectiveness of Aquablation compared to other treatments for patients with urinary symptoms caused by an enlarged prostate. The authors concluded that Aquablation is probably as effective as transurethral resection of the prostate (TURP) in these patients. Some background An enlarged prostate may cause...
Read More
In a nutshell This study examined if men taking 5α-reductase inhibitors (5ARIs) for benign prostatic hyperplasia (BPH) are more likely to develop type 2 diabetes (T2D). This study concluded the risk of developing T2D is higher in patients taking 5ARIs for BPH, compared to alpha blockers. Some background Benign Prostatic Hyperplasia...
Read More
In a nutshell This study investigated drug combinations with silodosin (Rapaflo) to treat overactive bladder (OAB) in men with benign prostatic hyperplasia (BPH). They found that fesoterodine (Toviaz) was more effective than mirabegron (Mirbetriq) as add-ons to silodosin in these patients. Some background Benign...
Read More
